Verona Pharma (NASDAQ:VRNA – Free Report) had its price target boosted by Wells Fargo & Company from $74.00 to $93.00 in a research report report published on Friday,Benzinga reports. They currently ...

The card features unlimited 2% cash back on all purchases, a sign-up bonus and a 0% intro APR promotion. When it comes to flat-rate cash-back cards, it's hard to beat 2% back, especially when the ...

Following Trump's lead, organizations including Walmart, Lowe’s and Meta have announced they would scale back their ...

We recently published a list of Israel Englander’s Stock Portfolio: Top 10 Stocks to Invest in. In this article, we are going ...

Impax Asset Management Group plc reduced its stake in Marsh & McLennan Companies, Inc. by 14.4%, selling 261,439 shares in Q4 ...

The acquisition will include the transfer of almost all WFCMS full-time employees based in the U.S. and India, a small group of divested Wells Fargo technology and compliance support staff, and ...

Shares of Wells Fargo & Company WFC have surged 58% in the past year compared with the industry’s rise of 58.5%. It has fared ...

Wells Fargo & Co. has satisfied the requirements of a consent order issued by the Consumer Financial Protection Bureau, its seventh resolution since 2019 of a consent order set by federal ...

Brookfield Asset Management (NYSE:BAM – Free Report) (TSE:BAM.A) had its price objective cut by Wells Fargo & Company from $55.00 to $54.00 in a research note issued to investors on Thursday ...

Wells Fargo reported its fourth-quarter ... an increase in asset-based fees in Wealth and Investment Management on higher market valuations, and higher investment banking fees, as well as ...

A month has gone by since the last earnings report for Wells Fargo (WFC ... an increase in asset-based fees in Wealth and Investment Management on higher market valuations, and higher investment ...